(3S,6S,9S,15R,21S,24S,27S,30S,33S,39S,42S,45S)-N,3-bis(2-amino-2-oxoethyl)-9-benzyl-21,24-dibutyl-18-(3-carbamimidamidopropyl)-30-(hydroxymethyl)-39-[(4-hydroxyphenyl)methyl]-42-(1H-imidazol-5-ylmethyl)-27,33-bis(1H-indol-3-ylmethyl)-6,7,22,25,37-pentamethyl-2,5,8,11,17,20,23,26,29,32,35,38,41,44-tetradecaoxo-13-thia-1,4,7,10,16,19,22,25,28,31,34,37,40,43-tetradecazabicyclo[43.3.0]octatetracontane-15-carboxamide

C92H124N24O19S — CID 146243455

IUPAC(3S,6S,9S,15R,21S,24S,27S,30S,33S,39S,42S,45S)-N,3-bis(2-amino-2-oxoethyl)-9-benzyl-21,24-dibutyl-18-(3-carbamimidamidopropyl)-30-(hydroxymethyl)-39-[(4-hydroxyphenyl)methyl]-42-(1H-imidazol-5-ylmethyl)-27,33-bis(1H-indol-3-ylmethyl)-6,7,22,25,37-pentamethyl-2,5,8,11,17,20,23,26,29,32,35,38,41,44-tetradecaoxo-13-thia-1,4,7,10,16,19,22,25,28,31,34,37,40,43-tetradecazabicyclo[43.3.0]octatetracontane-15-carboxamide
SMILES[H]/N=C(\N)NCCCC1NC(=O)[C@H](CCCC)N(C)C(=O)[C@H](CCCC)N(C)C(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CO)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)CN(C)C(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)N(C)C(=O)[C@H](Cc2ccccc2)NC(=O)CSC[C@@H](C(=O)NCC(N)=O)NC1=O
InChIInChI=1S/C92H124N24O19S/c1-8-10-28-72-85(129)105-63(27-19-35-98-92(95)96)81(125)111-71(80(124)101-46-76(94)120)49-136-50-78(122)104-67(37-53-21-13-12-14-22-53)88(132)113(5)52(3)79(123)107-69(42-75(93)119)90(134)116-36-20-30-73(116)86(130)106-65(41-57-45-97-51-102-57)83(127)108-66(38-54-31-33-58(118)34-32-54)87(131)112(4)47-77(121)103-64(39-55-43-99-61-25-17-15-23-59(55)61)82(126)110-70(48-117)84(128)109-68(40-56-44-100-62-26-18-16-24-60(56)62)89(133)115(7)74(29-11-9-2)91(135)114(72)6/h12-18,21-26,31-34,43-45,51-52,63-74,99-100,117-118H,8-11,19-20,27-30,35-42,46-50H2,1-7H3,(H2,93,119)(H2,94,120)(H,97,102)(H,101,124)(H,103,121)(H,104,122)(H,105,129)(H,106,130)(H,107,123)(H,108,127)(H,109,128)(H,110,126)(H,111,125)(H4,95,96,98)/t52-,63?,64-,65-,66-,67-,68-,69-,70-,71-,72-,73-,74-/m0/s1
InChIKeyUNIWCWOKAYLQOX-UFAFKFNDSA-N
MW1902.22 g/mol
LogP-2.24
Rot. Bonds26

About (3S,6S,9S,15R,21S,24S,27S,30S,33S,39S,42S,45S)-N,3-bis(2-amino-2-oxoethyl)-9-benzyl-21,24-dibutyl-18-(3-carbamimidamidopropyl)-30-(hydroxymethyl)-39-[(4-hydroxyphenyl)methyl]-42-(1H-imidazol-5-ylmethyl)-27,33-bis(1H-indol-3-ylmethyl)-6,7,22,25,37-pentamethyl-2,5,8,11,17,20,23,26,29,32,35,38,41,44-tetradecaoxo-13-thia-1,4,7,10,16,19,22,25,28,31,34,37,40,43-tetradecazabicyclo[43.3.0]octatetracontane-15-carboxamide

(3S,6S,9S,15R,21S,24S,27S,30S,33S,39S,42S,45S)-N,3-bis(2-amino-2-oxoethyl)-9-benzyl-21,24-dibutyl-18-(3-carbamimidamidopropyl)-30-(hydroxymethyl)-39-[(4-hydroxyphenyl)methyl]-42-(1H-imidazol-5-ylmethyl)-27,33-bis(1H-indol-3-ylmethyl)-6,7,22,25,37-pentamethyl-2,5,8,11,17,20,23,26,29,32,35,38,41,44-tetradecaoxo-13-thia-1,4,7,10,16,19,22,25,28,31,34,37,40,43-tetradecazabicyclo[43.3.0]octatetracontane-15-carboxamide (PubChem CID 146243455) has the molecular formula C92H124N24O19S and a molecular weight of 1902.22 g/mol. Its IUPAC name is (3S,6S,9S,15R,21S,24S,27S,30S,33S,39S,42S,45S)-N,3-bis(2-amino-2-oxoethyl)-9-benzyl-21,24-dibutyl-18-(3-carbamimidamidopropyl)-30-(hydroxymethyl)-39-[(4-hydroxyphenyl)methyl]-42-(1H-imidazol-5-ylmethyl)-27,33-bis(1H-indol-3-ylmethyl)-6,7,22,25,37-pentamethyl-2,5,8,11,17,20,23,26,29,32,35,38,41,44-tetradecaoxo-13-thia-1,4,7,10,16,19,22,25,28,31,34,37,40,43-tetradecazabicyclo[43.3.0]octatetracontane-15-carboxamide.

Molecular Properties

Compound Name(3S,6S,9S,15R,21S,24S,27S,30S,33S,39S,42S,45S)-N,3-bis(2-amino-2-oxoethyl)-9-benzyl-21,24-dibutyl-18-(3-carbamimidamidopropyl)-30-(hydroxymethyl)-39-[(4-hydroxyphenyl)methyl]-42-(1H-imidazol-5-ylmethyl)-27,33-bis(1H-indol-3-ylmethyl)-6,7,22,25,37-pentamethyl-2,5,8,11,17,20,23,26,29,32,35,38,41,44-tetradecaoxo-13-thia-1,4,7,10,16,19,22,25,28,31,34,37,40,43-tetradecazabicyclo[43.3.0]octatetracontane-15-carboxamide
PubChem CID146243455
Molecular FormulaC92H124N24O19S
Molecular Weight1902.22 g/mol
Exact Mass1900.92
IUPAC Name(3S,6S,9S,15R,21S,24S,27S,30S,33S,39S,42S,45S)-N,3-bis(2-amino-2-oxoethyl)-9-benzyl-21,24-dibutyl-18-(3-carbamimidamidopropyl)-30-(hydroxymethyl)-39-[(4-hydroxyphenyl)methyl]-42-(1H-imidazol-5-ylmethyl)-27,33-bis(1H-indol-3-ylmethyl)-6,7,22,25,37-pentamethyl-2,5,8,11,17,20,23,26,29,32,35,38,41,44-tetradecaoxo-13-thia-1,4,7,10,16,19,22,25,28,31,34,37,40,43-tetradecazabicyclo[43.3.0]octatetracontane-15-carboxamide
SMILES[H]/N=C(\N)NCCCC1NC(=O)[C@H](CCCC)N(C)C(=O)[C@H](CCCC)N(C)C(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CO)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)CN(C)C(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)N(C)C(=O)[C@H](Cc2ccccc2)NC(=O)CSC[C@@H](C(=O)NCC(N)=O)NC1=O
InChIInChI=1S/C92H124N24O19S/c1-8-10-28-72-85(129)105-63(27-19-35-98-92(95)96)81(125)111-71(80(124)101-46-76(94)120)49-136-50-78(122)104-67(37-53-21-13-12-14-22-53)88(132)113(5)52(3)79(123)107-69(42-75(93)119)90(134)116-36-20-30-73(116)86(130)106-65(41-57-45-97-51-102-57)83(127)108-66(38-54-31-33-58(118)34-32-54)87(131)112(4)47-77(121)103-64(39-55-43-99-61-25-17-15-23-59(55)61)82(126)110-70(48-117)84(128)109-68(40-56-44-100-62-26-18-16-24-60(56)62)89(133)115(7)74(29-11-9-2)91(135)114(72)6/h12-18,21-26,31-34,43-45,51-52,63-74,99-100,117-118H,8-11,19-20,27-30,35-42,46-50H2,1-7H3,(H2,93,119)(H2,94,120)(H,97,102)(H,101,124)(H,103,121)(H,104,122)(H,105,129)(H,106,130)(H,107,123)(H,108,127)(H,109,128)(H,110,126)(H,111,125)(H4,95,96,98)/t52-,63?,64-,65-,66-,67-,68-,69-,70-,71-,72-,73-,74-/m0/s1
InChIKeyUNIWCWOKAYLQOX-UFAFKFNDSA-N
XLogP-2.24
TPSA641.35 Ų
H-Bond Donors20
H-Bond Acceptors22
Rotatable Bonds26
Heavy Atoms136
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001902.22
LogP ≤ 5-2.24
H-Bond Donors ≤ 520
H-Bond Acceptors ≤ 1022

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'imine_2', 'substructure': 'N/A'}

Analyze (3S,6S,9S,15R,21S,24S,27S,30S,33S,39S,42S,45S)-N,3-bis(2-amino-2-oxoethyl)-9-benzyl-21,24-dibutyl-18-(3-carbamimidamidopropyl)-30-(hydroxymethyl)-39-[(4-hydroxyphenyl)methyl]-42-(1H-imidazol-5-ylmethyl)-27,33-bis(1H-indol-3-ylmethyl)-6,7,22,25,37-pentamethyl-2,5,8,11,17,20,23,26,29,32,35,38,41,44-tetradecaoxo-13-thia-1,4,7,10,16,19,22,25,28,31,34,37,40,43-tetradecazabicyclo[43.3.0]octatetracontane-15-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (3S,6S,9S,15R,21S,24S,27S,30S,33S,39S,42S,45S)-N,3-bis(2-amino-2-oxoethyl)-9-benzyl-21,24-dibutyl-18-(3-carbamimidamidopropyl)-30-(hydroxymethyl)-39-[(4-hydroxyphenyl)methyl]-42-(1H-imidazol-5-ylmethyl)-27,33-bis(1H-indol-3-ylmethyl)-6,7,22,25,37-pentamethyl-2,5,8,11,17,20,23,26,29,32,35,38,41,44-tetradecaoxo-13-thia-1,4,7,10,16,19,22,25,28,31,34,37,40,43-tetradecazabicyclo[43.3.0]octatetracontane-15-carboxamide?
The IUPAC name of (3S,6S,9S,15R,21S,24S,27S,30S,33S,39S,42S,45S)-N,3-bis(2-amino-2-oxoethyl)-9-benzyl-21,24-dibutyl-18-(3-carbamimidamidopropyl)-30-(hydroxymethyl)-39-[(4-hydroxyphenyl)methyl]-42-(1H-imidazol-5-ylmethyl)-27,33-bis(1H-indol-3-ylmethyl)-6,7,22,25,37-pentamethyl-2,5,8,11,17,20,23,26,29,32,35,38,41,44-tetradecaoxo-13-thia-1,4,7,10,16,19,22,25,28,31,34,37,40,43-tetradecazabicyclo[43.3.0]octatetracontane-15-carboxamide (CID 146243455) is (3S,6S,9S,15R,21S,24S,27S,30S,33S,39S,42S,45S)-N,3-bis(2-amino-2-oxoethyl)-9-benzyl-21,24-dibutyl-18-(3-carbamimidamidopropyl)-30-(hydroxymethyl)-39-[(4-hydroxyphenyl)methyl]-42-(1H-imidazol-5-ylmethyl)-27,33-bis(1H-indol-3-ylmethyl)-6,7,22,25,37-pentamethyl-2,5,8,11,17,20,23,26,29,32,35,38,41,44-tetradecaoxo-13-thia-1,4,7,10,16,19,22,25,28,31,34,37,40,43-tetradecazabicyclo[43.3.0]octatetracontane-15-carboxamide.
What is the SMILES notation for (3S,6S,9S,15R,21S,24S,27S,30S,33S,39S,42S,45S)-N,3-bis(2-amino-2-oxoethyl)-9-benzyl-21,24-dibutyl-18-(3-carbamimidamidopropyl)-30-(hydroxymethyl)-39-[(4-hydroxyphenyl)methyl]-42-(1H-imidazol-5-ylmethyl)-27,33-bis(1H-indol-3-ylmethyl)-6,7,22,25,37-pentamethyl-2,5,8,11,17,20,23,26,29,32,35,38,41,44-tetradecaoxo-13-thia-1,4,7,10,16,19,22,25,28,31,34,37,40,43-tetradecazabicyclo[43.3.0]octatetracontane-15-carboxamide?
The canonical SMILES for (3S,6S,9S,15R,21S,24S,27S,30S,33S,39S,42S,45S)-N,3-bis(2-amino-2-oxoethyl)-9-benzyl-21,24-dibutyl-18-(3-carbamimidamidopropyl)-30-(hydroxymethyl)-39-[(4-hydroxyphenyl)methyl]-42-(1H-imidazol-5-ylmethyl)-27,33-bis(1H-indol-3-ylmethyl)-6,7,22,25,37-pentamethyl-2,5,8,11,17,20,23,26,29,32,35,38,41,44-tetradecaoxo-13-thia-1,4,7,10,16,19,22,25,28,31,34,37,40,43-tetradecazabicyclo[43.3.0]octatetracontane-15-carboxamide is [H]/N=C(\N)NCCCC1NC(=O)[C@H](CCCC)N(C)C(=O)[C@H](CCCC)N(C)C(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CO)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)CN(C)C(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)N(C)C(=O)[C@H](Cc2ccccc2)NC(=O)CSC[C@@H](C(=O)NCC(N)=O)NC1=O.
What is the InChIKey of (3S,6S,9S,15R,21S,24S,27S,30S,33S,39S,42S,45S)-N,3-bis(2-amino-2-oxoethyl)-9-benzyl-21,24-dibutyl-18-(3-carbamimidamidopropyl)-30-(hydroxymethyl)-39-[(4-hydroxyphenyl)methyl]-42-(1H-imidazol-5-ylmethyl)-27,33-bis(1H-indol-3-ylmethyl)-6,7,22,25,37-pentamethyl-2,5,8,11,17,20,23,26,29,32,35,38,41,44-tetradecaoxo-13-thia-1,4,7,10,16,19,22,25,28,31,34,37,40,43-tetradecazabicyclo[43.3.0]octatetracontane-15-carboxamide?
The InChIKey is UNIWCWOKAYLQOX-UFAFKFNDSA-N. The full InChI is InChI=1S/C92H124N24O19S/c1-8-10-28-72-85(129)105-63(27-19-35-98-92(95)96)81(125)111-71(80(124)101-46-76(94)120)49-136-50-78(122)104-67(37-53-21-13-12-14-22-53)88(132)113(5)52(3)79(123)107-69(42-75(93)119)90(134)116-36-20-30-73(116)86(130)106-65(41-57-45-97-51-102-57)83(127)108-66(38-54-31-33-58(118)34-32-54)87(131)112(4)47-77(121)103-64(39-55-43-99-61-25-17-15-23-59(55)61)82(126)110-70(48-117)84(128)109-68(40-56-44-100-62-26-18-16-24-60(56)62)89(133)115(7)74(29-11-9-2)91(135)114(72)6/h12-18,21-26,31-34,43-45,51-52,63-74,99-100,117-118H,8-11,19-20,27-30,35-42,46-50H2,1-7H3,(H2,93,119)(H2,94,120)(H,97,102)(H,101,124)(H,103,121)(H,104,122)(H,105,129)(H,106,130)(H,107,123)(H,108,127)(H,109,128)(H,110,126)(H,111,125)(H4,95,96,98)/t52-,63?,64-,65-,66-,67-,68-,69-,70-,71-,72-,73-,74-/m0/s1.
What are the key properties of (3S,6S,9S,15R,21S,24S,27S,30S,33S,39S,42S,45S)-N,3-bis(2-amino-2-oxoethyl)-9-benzyl-21,24-dibutyl-18-(3-carbamimidamidopropyl)-30-(hydroxymethyl)-39-[(4-hydroxyphenyl)methyl]-42-(1H-imidazol-5-ylmethyl)-27,33-bis(1H-indol-3-ylmethyl)-6,7,22,25,37-pentamethyl-2,5,8,11,17,20,23,26,29,32,35,38,41,44-tetradecaoxo-13-thia-1,4,7,10,16,19,22,25,28,31,34,37,40,43-tetradecazabicyclo[43.3.0]octatetracontane-15-carboxamide?
(3S,6S,9S,15R,21S,24S,27S,30S,33S,39S,42S,45S)-N,3-bis(2-amino-2-oxoethyl)-9-benzyl-21,24-dibutyl-18-(3-carbamimidamidopropyl)-30-(hydroxymethyl)-39-[(4-hydroxyphenyl)methyl]-42-(1H-imidazol-5-ylmethyl)-27,33-bis(1H-indol-3-ylmethyl)-6,7,22,25,37-pentamethyl-2,5,8,11,17,20,23,26,29,32,35,38,41,44-tetradecaoxo-13-thia-1,4,7,10,16,19,22,25,28,31,34,37,40,43-tetradecazabicyclo[43.3.0]octatetracontane-15-carboxamide has a molecular weight of 1902.22 g/mol, XLogP of -2.24, 26 rotatable bonds, 20 hydrogen bond donors, and 22 hydrogen bond acceptors.
Where does this data come from?
All data for (3S,6S,9S,15R,21S,24S,27S,30S,33S,39S,42S,45S)-N,3-bis(2-amino-2-oxoethyl)-9-benzyl-21,24-dibutyl-18-(3-carbamimidamidopropyl)-30-(hydroxymethyl)-39-[(4-hydroxyphenyl)methyl]-42-(1H-imidazol-5-ylmethyl)-27,33-bis(1H-indol-3-ylmethyl)-6,7,22,25,37-pentamethyl-2,5,8,11,17,20,23,26,29,32,35,38,41,44-tetradecaoxo-13-thia-1,4,7,10,16,19,22,25,28,31,34,37,40,43-tetradecazabicyclo[43.3.0]octatetracontane-15-carboxamide is sourced from PubChem (CID 146243455), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).